Press release
University of Dundee spinout Amphista Therapeutics has been designated as one of the world’s most promising biotechnology companies.
Press release
University of Dundee spinout Amphista Therapeutics has been designated as one of the world’s most promising biotechnology companies.
Press release
The University of Dundee and Bio-Techne, a global life sciences company providing innovative tools and bioactive reagents, will partner to commercialise technology developed at Dundee that enhances the understanding of undruggable diseases.
Impact case study
Shaping the future of commercial drug development and driving global pharmaceutical investment.
Press release
The University of Dundee has been confirmed as one of the UK’s leading research centres for biological sciences, according to the results of the Research Excellence Framework (REF 2021)
Impact case study
Bringing about step-change in the diagnosis and treatment of neglected tropical diseases.
Press release
University of Dundee spinout Amphista Therapeutics will work with global biopharmaceutical companies as part of strategic collaborations potentially worth more than $2 billion.
News
Amphista Therapeutics, the spin out company from the lab of Professor Alessio Ciulli, was awarded the ‘Financing Deal of the Year’ award 2021 at the Scrip Awards last month. This was in recognition of their $53M Series B funding.
News
Evotec invests in Exscientia to advance AI-driven drug discovery
News
A new diagnostic test developed from research at the Universities of Dundee and Cambridge has been launched with the aim of helping eliminate the disease known as African sleeping sickness.
News
Pre-clinical collaboration focused on up to 10 targets nominated by GSK